vs

Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $44.6M, roughly 1.3× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -90.4%, a 77.9% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 13.8%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -0.0%).

CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

CBAT vs PACB — Head-to-Head

Bigger by revenue
CBAT
CBAT
1.3× larger
CBAT
$58.8M
$44.6M
PACB
Growing faster (revenue YoY)
CBAT
CBAT
+118.0% gap
CBAT
131.8%
13.8%
PACB
Higher net margin
CBAT
CBAT
77.9% more per $
CBAT
-12.5%
-90.4%
PACB
More free cash flow
CBAT
CBAT
$36.0M more FCF
CBAT
$16.1M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-0.0%
CBAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBAT
CBAT
PACB
PACB
Revenue
$58.8M
$44.6M
Net Profit
$-7.4M
$-40.4M
Gross Margin
7.3%
37.1%
Operating Margin
-13.6%
-92.3%
Net Margin
-12.5%
-90.4%
Revenue YoY
131.8%
13.8%
Net Profit YoY
-63.6%
-1802.7%
EPS (diluted)
$-0.08
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAT
CBAT
PACB
PACB
Q4 25
$58.8M
$44.6M
Q3 25
$60.9M
$38.4M
Q2 25
$40.5M
$39.8M
Q1 25
$34.9M
$37.2M
Q4 24
$25.4M
$39.2M
Q3 24
$44.6M
$40.0M
Q2 24
$47.8M
$36.0M
Q1 24
$58.8M
$38.8M
Net Profit
CBAT
CBAT
PACB
PACB
Q4 25
$-7.4M
$-40.4M
Q3 25
$2.7M
$-38.0M
Q2 25
$-3.1M
$-41.9M
Q1 25
$-1.6M
$-426.1M
Q4 24
$-4.5M
$2.4M
Q3 24
$17.6K
$-60.7M
Q2 24
$6.4M
$-173.3M
Q1 24
$9.8M
$-78.2M
Gross Margin
CBAT
CBAT
PACB
PACB
Q4 25
7.3%
37.1%
Q3 25
8.0%
41.4%
Q2 25
11.0%
36.9%
Q1 25
13.7%
-3.7%
Q4 24
13.1%
25.6%
Q3 24
15.6%
25.0%
Q2 24
26.6%
16.5%
Q1 24
31.9%
29.1%
Operating Margin
CBAT
CBAT
PACB
PACB
Q4 25
-13.6%
-92.3%
Q3 25
-6.6%
-101.1%
Q2 25
-8.7%
-112.8%
Q1 25
-8.2%
-1154.5%
Q4 24
-26.0%
-390.1%
Q3 24
-1.9%
-160.3%
Q2 24
12.4%
-488.3%
Q1 24
17.4%
-209.6%
Net Margin
CBAT
CBAT
PACB
PACB
Q4 25
-12.5%
-90.4%
Q3 25
4.4%
-98.9%
Q2 25
-7.6%
-105.4%
Q1 25
-4.5%
-1146.8%
Q4 24
-17.8%
6.0%
Q3 24
0.0%
-151.9%
Q2 24
13.5%
-481.3%
Q1 24
16.7%
-201.4%
EPS (diluted)
CBAT
CBAT
PACB
PACB
Q4 25
$-0.08
$-0.11
Q3 25
$0.03
$-0.13
Q2 25
$-0.03
$-0.14
Q1 25
$-0.02
$-1.44
Q4 24
$-0.05
$-0.44
Q3 24
$0.00
$-0.22
Q2 24
$0.07
$-0.64
Q1 24
$0.11
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAT
CBAT
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$8.3M
$279.5M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$112.7M
$5.3M
Total Assets
$426.2M
$784.1M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAT
CBAT
PACB
PACB
Q4 25
$8.3M
$279.5M
Q3 25
$10.5M
$298.7M
Q2 25
$45.7M
$314.7M
Q1 25
$9.6M
$343.1M
Q4 24
$11.0M
$389.9M
Q3 24
$24.2M
$471.1M
Q2 24
$44.1M
$509.8M
Q1 24
$23.8M
$561.9M
Total Debt
CBAT
CBAT
PACB
PACB
Q4 25
$4.1M
Q3 25
$4.8M
Q2 25
$4.9M
Q1 25
$4.1M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CBAT
CBAT
PACB
PACB
Q4 25
$112.7M
$5.3M
Q3 25
$121.4M
$36.1M
Q2 25
$118.2M
$61.5M
Q1 25
$120.8M
$91.6M
Q4 24
$121.7M
$506.6M
Q3 24
$131.2M
$453.1M
Q2 24
$126.6M
$492.7M
Q1 24
$120.9M
$649.0M
Total Assets
CBAT
CBAT
PACB
PACB
Q4 25
$426.2M
$784.1M
Q3 25
$363.9M
$803.2M
Q2 25
$333.1M
$825.5M
Q1 25
$311.5M
$860.8M
Q4 24
$302.2M
$1.3B
Q3 24
$293.5M
$1.5B
Q2 24
$279.6M
$1.5B
Q1 24
$286.5M
$1.7B
Debt / Equity
CBAT
CBAT
PACB
PACB
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.03×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAT
CBAT
PACB
PACB
Operating Cash FlowLast quarter
$29.8M
$-19.1M
Free Cash FlowOCF − Capex
$16.1M
$-19.9M
FCF MarginFCF / Revenue
27.3%
-44.6%
Capex IntensityCapex / Revenue
23.4%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAT
CBAT
PACB
PACB
Q4 25
$29.8M
$-19.1M
Q3 25
$14.6M
$-18.7M
Q2 25
$13.8M
$-29.4M
Q1 25
$-9.6M
$-44.1M
Q4 24
$9.6M
$-30.6M
Q3 24
$19.7M
$-45.5M
Q2 24
$2.9M
$-54.3M
Q1 24
$7.4M
$-75.7M
Free Cash Flow
CBAT
CBAT
PACB
PACB
Q4 25
$16.1M
$-19.9M
Q3 25
$6.0M
$-18.8M
Q2 25
$4.1M
$-29.9M
Q1 25
$-22.3M
$-45.4M
Q4 24
$3.9M
$-32.3M
Q3 24
$16.5M
$-46.3M
Q2 24
$2.5M
$-55.7M
Q1 24
$-454.0K
$-79.6M
FCF Margin
CBAT
CBAT
PACB
PACB
Q4 25
27.3%
-44.6%
Q3 25
9.9%
-48.9%
Q2 25
10.2%
-75.3%
Q1 25
-63.9%
-122.3%
Q4 24
15.5%
-82.3%
Q3 24
37.1%
-115.7%
Q2 24
5.2%
-154.8%
Q1 24
-0.8%
-205.0%
Capex Intensity
CBAT
CBAT
PACB
PACB
Q4 25
23.4%
1.9%
Q3 25
14.1%
0.2%
Q2 25
23.8%
1.4%
Q1 25
36.3%
3.7%
Q4 24
22.5%
4.1%
Q3 24
7.0%
2.0%
Q2 24
0.9%
4.1%
Q1 24
13.4%
10.0%
Cash Conversion
CBAT
CBAT
PACB
PACB
Q4 25
Q3 25
5.51×
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
1115.72×
Q2 24
0.46×
Q1 24
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAT
CBAT

Manufacturing Lithium Batteries$28.0M48%
Residential Energy Supply And Uninterruptable Supplies$17.8M30%
Light Electric Vehicles$12.9M22%
Precursor$108.0K0%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons